The Food and Drug Administration (FDA) has approved Yesintek TM (ustekinumab-kfce), a biosimilar to Stelara ® (Ustekinumab), for the treatment of various chronic inflammatory diseases. Yesintek, ...
The Supreme Court appeared unsympathetic Monday to a challenge from the maker of flavored e-cigarette products to an FDA decision denying authorization to bring them to market.